Manhattan Scientifics Inc (MHTX)

[Hncher]

Condescending as usual and yes, I read it.

"After optimizing the in vitro sensitivity, we plan to test the ability of the MRX instrument for detecting ovarian cancer xenografts. We also have the goal of developing sophisticated inverse problem reconstruction techniques that allow for recovery of a high dimensional relaxation field. Finally, we hope to deploy the first human prototype system in our clinics in the next few years."

This was recently added to the site, so it can't be 7 years old.

On another point, it is NOT 7 years, the collaboration with MDA was in January 2014.

Please point to me to where Manny said "those results would appear in a peer reviewed article in the near future" I may have missed it.